Clinical Coordinating Center for the Severe Asthma Research Program (SARP)

严重哮喘研究计划临床协调中心 (SARP)

基本信息

项目摘要

DESCRIPTION (provided by applicant): The overall goal of the Severe Asthma Research Program (SARP) is to develop a new paradigm for the understanding of severe asthma and its sub-phenotypes, in children and adults, by defining disease longitudinally at the molecular and cellular level. The Department of Public Health Sciences at the Penn State College of Medicine proposes to serve as the Clinical Coordinating Center (CCC) for SARP. The CCC will provide biostatistical leadership and scientific coordination for SARP; design and maintain the SARP operations management system; provide logistical and communications support for SARP; and distribute funds for a shared longitudinal protocol. The Department of Public Health Sciences is uniquely qualified to serve as the Clinical Coordinating Center for SARP, as the home of the Asthma Clinical Research Network (ACRN) and the Childhood Asthma Research and Education (CARE) Data Coordinating Centers since their inceptions in 1993 and 1999, respectively, and the AsthmaNet DCC since 2009. The PI and core biostatistician of this application is David T. Mauger, PhD, who is currently the PI of the CARE and Asthma Net DCCs. Dr. Mauger will head a DPHS team well-experienced in data collection and management, biostatistical design and analysis, quality control, network infrastructure development and maintenance, and working with national repositories and oversight committees. This application also includes a very strong clinical co-investigator with extensive research experience in asthma, Joanna Floros, PhD. Although there will be many clinician investigators at the network clinical centers who are leaders in the field, frequent, direct interaction between CCC personnel and local co-investigators with clinical expertise greatly facilitates the activities of the CCC. In summary, through its long history of managing successful data coordinating centers, Penn State College of Medicine's Department of Public Health Sciences is well poised to successfully implement and execute the Severe Asthma Research Program. PUBLIC HEALTH RELEVANCE: RELEVANCE (See instructions): By integrating genetic, epigenetic, genomic and other approaches to identify pathobiologic processes and validate biomarkers that correlate over time with sub-phenotype progression, we expect to develop practical biomarker-based tools to predict loss of symptom control and risk of exacerbation. This will serve to ameliorate a part of the burden of Asthma, a disease which affects 22 million people in the United States.
描述(申请人提供):重症哮喘研究计划(SARP)的总体目标是开发一种新的范式,通过在分子和细胞水平上纵向定义疾病,来理解儿童和成人的严重哮喘及其亚型。宾夕法尼亚州立医学院公共卫生科学系建议作为SARP的临床协调中心(CCC)。协调中心将为SARP提供生物统计领导和科学协调;设计和维护SARP业务管理系统;为SARP提供后勤和通信支持;并为共同的纵向议定书分配资金。公共卫生科学部是唯一有资格担任SARP临床协调中心的机构,自1993年和1999年成立以来,分别是哮喘临床研究网络(ACRN)和儿童哮喘研究和教育(CARE)数据协调中心的所在地,自2009年以来,是哮喘网络数据协调中心的所在地。该应用程序的PI和核心生物统计师是David T.Mauger博士,他目前是CARE和哮喘网疾病预防控制中心的PI。Mauger博士将领导一个在数据收集和管理、生物统计设计和分析、质量控制、网络基础设施开发和维护以及与国家信息库和监督委员会合作方面经验丰富的DPHS团队。这项申请还包括一位非常强大的临床合作研究员,具有广泛的哮喘研究经验,乔安娜·弗洛罗斯博士。尽管网络临床中心将有许多临床医生调查人员是该领域的领导者,但CCC人员与具有临床专业知识的当地合作调查人员之间的频繁、直接互动极大地促进了CCC的活动。总而言之,宾夕法尼亚州立大学医学院公共卫生科学系凭借其管理成功的数据协调中心的长期历史,已经做好了成功实施和执行严重哮喘研究计划的准备。 公共卫生相关性:相关性(参见说明):通过整合遗传学、表观遗传学、基因组和其他方法来识别病理生物学过程,并验证随时间与亚表型进展相关的生物标记物,我们期望开发实用的基于生物标记物的工具来预测症状控制的丧失和恶化的风险。这将有助于减轻哮喘的部分负担,哮喘是一种影响美国2200万人的疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David T. Mauger其他文献

Outcome assessment of blunt trauma patients who are undertriaged
  • DOI:
    10.1016/j.surg.2010.05.004
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert A. Cherry;Eric Bradburn;Pamela A. Nichols;Theresa M. Snavely;Susan Janine Boehmer;David T. Mauger
  • 通讯作者:
    David T. Mauger
Impact of the Armed Forces Institute of Pathology Radiologic Pathology Course on radiology resident performance on the ACR In-Training and ABR written Examinations
  • DOI:
    10.1016/s1076-6332(00)80525-5
  • 发表时间:
    2000-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Scott W. Wise;David T. Mauger;Amy E. Matthews;David S. Hartman
  • 通讯作者:
    David S. Hartman
Asthma severity and corticosteroid response depend on variable type 1 and type 2 inflammation in the airway
哮喘严重程度和皮质类固醇反应取决于气道中不同的 1 型和 2 型炎症
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Fahy;Nathan D. Jackson;S. Sajuthi;E. Pruesse;Camille M Moore;J. Everman;C. Rios;M. Tang;Marc Gauthier;S. Wenzel;E. Bleecker;Mario Castro;S. Comhair;S. Erzurum;A. Hastie;Wendy C Moore;Elliot Israel;Bruce D. Levy;L. Denlinger;N. Jarjour;M. Johansson;David T. Mauger;B. Phillips;K. Sumino;Prescott G. Woodruff;M. Peters;Max A Seibold
  • 通讯作者:
    Max A Seibold
Growth of Preschool Children at High Risk for Asthma Two Years after Discontinuation of Fluticasone
停用氟替卡松两年后哮喘高危学龄前儿童的生长情况
  • DOI:
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Guilbert;David T. Mauger;David B. Allen;Robert S. Zeiger;R. Lemanske;Stanley J. Szefler;R. Strunk;L. Bacharier;R. Covar;C. Sorkness;Lynn;M. Taussig;Fernando D. Martinez
  • 通讯作者:
    Fernando D. Martinez

David T. Mauger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David T. Mauger', 18)}}的其他基金

ORBEX: Primary Prevention of Asthma and Wheezing in Children-DCC
ORBEX:儿童哮喘和喘息的一级预防-DCC
  • 批准号:
    9268570
  • 财政年份:
    2016
  • 资助金额:
    $ 98.55万
  • 项目类别:
ORBEX: Primary Prevention of Asthma and Wheezing in Children-DCC
ORBEX:儿童哮喘和喘息的一级预防-DCC
  • 批准号:
    9487706
  • 财政年份:
    2016
  • 资助金额:
    $ 98.55万
  • 项目类别:
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
严重哮喘研究计划临床协调中心 (SARP)
  • 批准号:
    8318697
  • 财政年份:
    2011
  • 资助金额:
    $ 98.55万
  • 项目类别:
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
严重哮喘研究计划临床协调中心 (SARP)
  • 批准号:
    8680342
  • 财政年份:
    2011
  • 资助金额:
    $ 98.55万
  • 项目类别:
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
严重哮喘研究计划临床协调中心 (SARP)
  • 批准号:
    8469568
  • 财政年份:
    2011
  • 资助金额:
    $ 98.55万
  • 项目类别:
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
严重哮喘研究计划临床协调中心 (SARP)
  • 批准号:
    8914737
  • 财政年份:
    2011
  • 资助金额:
    $ 98.55万
  • 项目类别:
Clinical Coordinating Center for the Severe Asthma Research Program (SARP)
严重哮喘研究计划临床协调中心 (SARP)
  • 批准号:
    9564275
  • 财政年份:
    2011
  • 资助金额:
    $ 98.55万
  • 项目类别:
Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)
NHLBI 哮喘网络数据协调中心 (AsthmaNet)
  • 批准号:
    8103168
  • 财政年份:
    2009
  • 资助金额:
    $ 98.55万
  • 项目类别:
Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)
NHLBI 哮喘网络数据协调中心 (AsthmaNet)
  • 批准号:
    7766693
  • 财政年份:
    2009
  • 资助金额:
    $ 98.55万
  • 项目类别:
Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)
NHLBI 哮喘网络数据协调中心 (AsthmaNet)
  • 批准号:
    8694083
  • 财政年份:
    2009
  • 资助金额:
    $ 98.55万
  • 项目类别:

相似海外基金

Positive Affect and Pediatric Asthma: An Innovative Positive Psychology Model to Improve Asthma Management and Health
积极情绪与小儿哮喘:改善哮喘管理和健康的创新积极心理学模型
  • 批准号:
    10712703
  • 财政年份:
    2023
  • 资助金额:
    $ 98.55万
  • 项目类别:
How the immune response can affect influenza virus and asthma
免疫反应如何影响流感病毒和哮喘
  • 批准号:
    nhmrc : GNT1054081
  • 财政年份:
    2013
  • 资助金额:
    $ 98.55万
  • 项目类别:
    Early Career Fellowships
How do thick airway walls affect airway hyperresponsiveness in asthma?
气道壁厚如何影响哮喘气道高反应性?
  • 批准号:
    nhmrc : 512387
  • 财政年份:
    2008
  • 资助金额:
    $ 98.55万
  • 项目类别:
    NHMRC Project Grants
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
  • 批准号:
    6566335
  • 财政年份:
    2000
  • 资助金额:
    $ 98.55万
  • 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
  • 批准号:
    6504483
  • 财政年份:
    2000
  • 资助金额:
    $ 98.55万
  • 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
  • 批准号:
    6304309
  • 财政年份:
    1999
  • 资助金额:
    $ 98.55万
  • 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
  • 批准号:
    6114202
  • 财政年份:
    1998
  • 资助金额:
    $ 98.55万
  • 项目类别:
The way in which newly discovered protein messengers in the lung affect asthma
肺部新发现的蛋白质信使影响哮喘的方式
  • 批准号:
    nhmrc : 970947
  • 财政年份:
    1997
  • 资助金额:
    $ 98.55万
  • 项目类别:
    NHMRC Project Grants
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME?
哪些家庭过程会影响儿童哮喘的结局?
  • 批准号:
    6275437
  • 财政年份:
    1997
  • 资助金额:
    $ 98.55万
  • 项目类别:
WHAT FAMILY PROCESSES AFFECT CHILDHOOD ASTHMA OUTCOME
哪些家庭过程会影响儿童哮喘的结局
  • 批准号:
    6245226
  • 财政年份:
    1997
  • 资助金额:
    $ 98.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了